These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3155034

  • 1. Inotropic and vasoactive drugs for management of the critically ill.
    McGrath RB.
    Acute Care; ; 14-15():293-312. PubMed ID: 3155034
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic cardiovascular support.
    Zaloga GP, Prielipp RC, Butterworth JF, Royster RL.
    Crit Care Clin; 1993 Apr; 9(2):335-62. PubMed ID: 8490766
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Oxygen transport and tissue oxygenation in critically ill patients--value of volumes and vasoactive substances].
    Reinhart K, Hannemann L, Meier-Hellmann A.
    Klin Wochenschr; 1991 Apr; 69 Suppl 26():112-8. PubMed ID: 1813705
    [Abstract] [Full Text] [Related]

  • 5. Inotropic agents in the critically ill.
    Cuthbertson BH, Hunter J, Webster NR.
    Br J Hosp Med; 1991 Apr; 56(8):386-91. PubMed ID: 8909711
    [Abstract] [Full Text] [Related]

  • 6. [Myocardial oxygen consumption and relationship to cardiovascular effects of clinical inodilators].
    Honerjäger P, Mitrovic V, Schlepper M.
    Med Klin (Munich); 1994 Feb 15; 89(2):89-94. PubMed ID: 8164602
    [No Abstract] [Full Text] [Related]

  • 7. Milrinone: a positive inotropic vasodilator.
    Colucci WS, Jaski BE, Fifer MA, Wright RF, Braunwald E.
    Trans Assoc Am Physicians; 1984 Feb 15; 97():124-33. PubMed ID: 6535335
    [No Abstract] [Full Text] [Related]

  • 8. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE, Arlt A, Meissner A, Lins M.
    Eur J Med Res; 2007 Nov 05; 12(11):563-7. PubMed ID: 18024265
    [Abstract] [Full Text] [Related]

  • 9. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations.
    Heywood JT, Khan TA.
    Rev Cardiovasc Med; 2007 Nov 05; 8 Suppl 5():S22-9. PubMed ID: 18192950
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacologic support in cardiogenic shock.
    Rude RE.
    Adv Shock Res; 1983 Nov 05; 10():35-49. PubMed ID: 6349299
    [Abstract] [Full Text] [Related]

  • 12. [Vasoactive and inotropic drugs in acute heart failure].
    Ruiz-Laiglesia FJ, Camafort-Babkowski M.
    Med Clin (Barc); 2014 Mar 05; 142 Suppl 1():49-54. PubMed ID: 24930084
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of levosimendan on the energy balance: preclinical and clinical evidence.
    Nieminen MS, Pollesello P, Vajda G, Papp Z.
    J Cardiovasc Pharmacol; 2009 Apr 05; 53(4):302-10. PubMed ID: 19276987
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Acute effect of dobutamine and amrinone on hemodynamics and splanchnic perfusion in septic shock patients].
    Hernández G, Gigoux J, Bugedo G, Castillo L, Bruhn A, Tomicic V, Dagnino J.
    Rev Med Chil; 1999 Jun 05; 127(6):660-6. PubMed ID: 10513074
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vasoactive substances and their effects on nutrition in the critically ill patient.
    Allen JM.
    Nutr Clin Pract; 2012 Jun 05; 27(3):335-9. PubMed ID: 22504108
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.